Gene therapy for hemophilia is revolutionizing the way patients manage this blood disorder.With the recent breakthrough of Hemgenix, a gene therapy specifically designed for hemophilia B treatment, patients like Terence Blue can experience significant advantages, such as reduced dependence on regular clotting factor injections.